Tolerability and Acceptability of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-Analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tolerability and Acceptability of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-Analysis
Authors
Keywords
Atrial Fibrillation, Dabigatran, Venous Thromboembolism, Rivaroxaban, Apixaban
Journal
American Journal of Cardiovascular Drugs
Volume 15, Issue 4, Pages 259-265
Publisher
Springer Nature
Online
2015-06-19
DOI
10.1007/s40256-015-0132-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis
- (2014) Daniel Caldeira et al. HEART
- The risk of infection with new oral anticoagulants: A meta-analysis
- (2014) Daniel Caldeira et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Thromboembolic risk in the initiation, switch and interruption/re-initiation of oral anticoagulants: Do newcomers improve outcomes? Insights from a meta-analysis of RCTs
- (2014) Daniel Caldeira et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis
- (2014) Daniel Caldeira et al. JOURNAL OF NEUROLOGY
- Treatment Discontinuations With New Oral Agents for Long-term Anticoagulation: Insights From a Meta-analysis of 18 Randomized Trials Including 101,801 Patients
- (2014) Saurav Chatterjee et al. MAYO CLINIC PROCEEDINGS
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Impact of Study Size on Meta-analyses: Examination of Underpowered Studies in Cochrane Reviews
- (2013) Rebecca M. Turner et al. PLoS One
- Prevention of VTE in Orthopedic Surgery Patients
- (2012) Yngve Falck-Ytter et al. CHEST
- Antithrombotic Therapy for VTE Disease
- (2012) Clive Kearon et al. CHEST
- Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation
- (2012) Masatsugu Hori et al. CIRCULATION JOURNAL
- External and internal validity of open label or double-blind trials in oral anticoagulation: better, worse or just different?
- (2011) J. BEYER-WESTENDORF et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
- (2009) Andrea Cipriani et al. LANCET
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2009) Alessandro Liberati et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search